The use of opioids in fibromyalgia (Q28305020)

International Journal of Rheumatic Diseases

Europe PubMed Central

title

The use of opioids in fibromyalgia (English)

0 references

0 references

0 references

Emma K Guymer

2

0 references

author name string

Gene-Siew Ngian

series ordinal

1

0 references

Geoffrey O Littlejohn

series ordinal

3

0 references

language of work or name

English

0 references

publication date

February 2011

0 references

published in

0 references

volume

14

0 references

issue

1

0 references

page(s)

6-11

0 references

cites work

The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

The prevalence and characteristics of fibromyalgia in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Balanced treatments for fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Understanding fibromyalgia: lessons from the broader pain research community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Management of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

A difficult balance--pain management, drug safety, and the FDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Examination of opioid prescribing in Australia from 1992 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Fibromyalgia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Decreased central mu-opioid receptor availability in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Adverse effects of chronic opioid therapy for chronic musculoskeletal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1756-185X.2010.01567.X